BioCentury
ARTICLE | Distillery Therapeutics

Endocrine/metabolic; hepatic

August 16, 2018 4:06 PM UTC

Mouse studies suggest inhibiting the long non-coding RNA (lncRNA) Blnc1 could help treat obesity, hepatic steatosis and NASH. In liver samples from a mouse model of obesity and hepatic steatosis and a...

BCIQ Company Profiles

University of Michigan

BCIQ Target Profiles

Brown fat lncRNA 1 (Blnc1)